GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

ITonis ITNS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$153

FY2016FY2025

Net income

−$11,322

FY2016FY2025

Free cash flow

—

FY2016FY2025

Shareholders' equity

−$1.1m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$153$344$1,801$3,050$4,427$2,473$8,680$9,117$7,669$450
Operating income−$11,322−$9,628−$38,310−$8,290−$69,820−$47,910−$60,770−$71,320−$62,130−$417,620
Net income−$11,322−$9,628−$38,313−$7,573−$71,385−$48,506−$61,022−$71,793−$385,494−$422,703
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$136,401$137,774$92,353$19,148$23,741$53,566$49,132$57,193$58,404$368,495
Cash and short-term investments$392$1,764$443$738$3,501$2,149$2,098$4,950$15,199$9,689
Total liabilities$1.3m$1.3m$1.1m$1.1m$1.1m$1.1m$1.1m$1.0m$929,770$894,124
Debt$1.0m$1.0m$910,441$910,441$910,441$870,441$817,141$764,641$690,641$651,817
Shareholders' equity−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m−$1.0m−$943,157−$871,364−$525,629
Shares outstanding1,523m1,523m1,523m1,523m1,523m1,523m1,523m1,523m1,523m901m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations——−$111,813−$8,293−$38,648−$53,249−$55,352−$84,249−$60,314−$77,681
Capital spending——−$3—————−$13,000—
Free cash flow——−$111,816−$8,293−$38,648−$53,249−$55,352−$84,249−$73,314−$77,681

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue—$15—$19$40$94—$111
Operating income−$9,255−$705−$700−$1,251−$8,657−$741−$671−$7,814
Net income−$9,255−$705−$700−$1,251−$8,657−$741−$671−$7,814
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$137,328$138,295$137,150$136,401$136,653$137,211$137,102$137,774
Cash and short-term investments$1,318$2,285$1,140$392$644$1,201$1,092$1,764
Debt$1.0m$1.0m$1.0m$1.0m$1.0m$1.0m$1.0m$1.0m
Shareholders' equity−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m−$1.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-63.1%-42.7%—
Operating income10.9%-25.1%-31.7%
Net income14.3%-25.2%-31.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-4217.9%-1263.2%-1512.8%—
Net margin-4217.9%-1249.8%-1524.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-67.3-79.1-9.5-13.2-3.6-1.5-0.8-0.7-0.0-0.0
Price to sales——203.032.958.629.05.85.51.235.1

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return25%11%538%-52%186%24%-25%559%-56%6%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-1 split · 21 Mar 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.